The firms invests primarily in companies commercializing healthcare products, services, and technologies. Aisling Capital has raised about $1.8 billion in committed capital across 4 investment funds and has made 106 investments. Notable investments made by the firm include: Dermira, BridgeBio, Atreca, TransEnterix, ViewRay, T2 Biosystems, Arcus Biosciences, Aimmune Therapeutics, Eidos Therapeutics, and Avrobio.
Cynapsus Therapeutics is a pharmaceutical subsidiary of Sunovion developing a non-injectable rescue therapy for Parkinson’s disease symptoms. The company was founded in 2004 and is headquartered in Toronto, Ontario, Canada.
Ajax is an investment company focused on investing and working with companies in the medical technology field.
A clinical late-stage biopharmaceutical company in California that focuses on treatments of dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis.
T2 Biosystems is a Lexington, Massachusetts-based company developing diagnostic products targeting sepsis and in vitro diagnostic products intended to target sepsis, hemostasis, bacteria, and lyme disease founded in 2006 by Robin Toft.
A company that develops pathogen detection system for the food industry
A company that develops therapeutics for the treatment of cancer
BridgeBio Pharma is a Palo Alto, California-based company.
Earlens Corporation is a Menlo Park, California-based company.